StockData
Innoviva, Inc. logo

Innoviva, Inc. (INVA) stock

INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.30−0.19 (-1.03%)

Close on Nov 17, 2026Market cap $1.32BP/E 9.3Yield –

Earnings

Innoviva's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$106.10M
-1.6% on a year earlier
EPS, Q3 FY2026
-$1.03
$1.08 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Innoviva's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close$106.10M-1.6%-$1.03Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026during market hours$119.60M+19.3%-$1.14Release
Q1 FY2026ended Mar 31, 2026May 6, 2026during market hours$98.00M–$2.22Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026during market hours$114.60M–$1.94Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025during market hours$107.80M+20.4%$1.08Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025during market hours$100.28M+0.4%$0.77Release
Q1 FY2025ended Mar 31, 2025May 7, 2025during market hours–––Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024during market hours$89.51M+33.1%$0.02Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024during market hours$99.90M+23.3%-$0.55Release
Q1 FY2024ended Mar 31, 2024May 8, 2024during market hours$77.50M+1.5%$0.46Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Innoviva's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
IST U.S. net product salesFY2026$150.00M–NewAug 5, 2026
U.S. net product salesFY2026$150.00M–NewNov 4, 2026
IST U.S. net product salesFY2026$150.00M–NewFeb 25, 2026

Guidance history

Every forecast Innoviva put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026U.S. net product salesFY2026$150.00MNew
Aug 5, 2026IST U.S. net product salesFY2026$150.00MNew
Feb 25, 2026IST U.S. net product salesFY2026$150.00MNew
Feb 26, 2025U.S. net product salesFY2025$100.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Innoviva filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Update
  12. Results
  13. Results
  14. Update
  15. Results

See a number that looks wrong?